Table 2.
2001 | 2003 | 2005 | 2007 | 2009 | 2011 | |
---|---|---|---|---|---|---|
Estimated no. of PLHIV | 107,371 | 103,423 | 96,550 | 90,176 | 85,885 | 83,413 |
No. of health centres (HC)* | (850) | n.a. | n.a. | 957 | 967 | 1004 |
VCCT sites | 25 | 51 | 109 | 197 | 233 | 255 |
ART – no. of operational districts with ART sites | 1 | 4 | 32 | 49 | 52 | 55 |
No. of PLHIV receiving ART | 71 | 2230 | 12,355 | 26,664 | 37,315 | 46,481 |
Estimated no. of PLHIV needing ART† | 31,537 | 38,644 | 42,039 | 44,348 | 47,576 | 58,216 |
% PLHIV receiving ART/estimated no. of PLHIV needing ART | 0.2% | 5.8% | 29% | 60% | 78% | 80% |
Home-based care (HBC) – no. of HBC teams | 52 | n.a. | 261 | 253 | 328 | 354 |
No. of HC with HBC team | n.a. | n.a. | 366 | 683 | 742 | 841 |
No. of operational districts with HBC teams | n.a. | n.a. | n.a. | n.a. | 67 | 72 |
PMTCT – no. of HC offering HIV testing to pregnant women | 0 | 7 | 25 | 91 | 228 | 944 |
No. of pregnant women tested for HIV | n.a. | 18,553 | 46,468 | 95,277 | 144,236 | 314,953 |
% Pregnant women tested for HIV/estimated pregnant women | n.a. | 5.8% | 14.2% | 28.2% | 44.0% | 86.0% |
No. of HIV+ pregnant women receiving ARV^ for PMTCT | n.a. | 87 | 175 | 599 | 798 | 1014 |
% HIV+ pregnant women receiving ARV^ for PMTCT/HIV+ pregnant women | n.a. | 3.5% | 9.0% | 11.2% | 32.3% | 69.2% |
TB/HIV – no. of operational districts offering HIV testing to TB cases | n.a. | 9 | 15 | 52 | 74 | 77 |
% PLHIV screened for TB upon pre-ART enrolment | n.a. | n.a. | n.a. | n.a. | 34.5% | 85.0% |
No. of TB cases tested for HIV | n.a. | n.a. | n.a. | 17,105 | 28,246 | 32,544 |
% TB cases tested for HIV/TB cases | n.a. | n.a. | n.a. | 4.7% | 70.3% | 82.0% |
No. of HIV+ TB cases receiving ART | n.a. | n.a. | n.a. | 610 | 526 | 1083 |
% HIV+ TB cases receiving ART/HIV-positive TB cases | n.a. | n.a. | n.a. | 11.0% | 14.6% | 79.2% |
Reporting of the number of health centres was established in 2007. The figure for 2001 is an estimate;
ART eligibility criteria for adults changed in 2010 from CD4 count 200 to 350; ^ARV for PMTCT includes single dose nevirapine.
ARV for PMTCT includes single dose nevirapine.